Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Mechanisms and Innovations in Cardiac Resynchronization Therapy

NCT04221763 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04221763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Mechanisms and Innovations in Cardiac Resynchronization Therapy
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2019
Completion date
December 1, 2022
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left bundle-branch block, left ventricular systolic dysfunction, non-specific intraventricular conduction defect, right bundle-branch block